--- title: "SL Science Holding (SLBT) news: going concern and merger" url: "https://aibio.space/companies/sl-science/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "SLBT going concern and merger news: SL Science closes Horizon Space Acquisition II deal, files shell company report." --- SLBT SL Science Holding Limited NASDAQ · Taiwan # SL Science Holding (SLBT) news SLBT going concern and merger news Distress · 2026-06-18 ## [SL Science closes Horizon Space Acquisition II deal, files shell company report](https://aibio.space/news/sl-science-closes-horizon-space-acquisition-ii-deal-files-shell/) SL Science Holding completed its merger with Horizon Space Acquisition II on June 12, 2026. Its shell company report says its three product candidates are still in preclinical testing, and that its financial statements carry a going-concern warning. ## Latest SL Science Holding news 1. 2025-12-18 Mergers [SL Science Holding files F-4 for Horizon Space Acquisition II and SL BIO merger](https://aibio.space/news/sl-science-holding-files-f-4-horizon-space-acquisition-ii-sl-bio/) SL Science Holding's F-4 says the blank-check company's trust holds $69,000,000 and that its chairman would control about 58% of the voting power of the combined company. The target's main products include cancer drugs that the filing does not show as approved. ## SL Science Holding at a glance - **Ticker**: SLBT - **Listing**: NASDAQ - **Country**: Taiwan ### Related companies - [Panion & BF Biotech](https://aibio.space/companies/panion-bf-biotech/) TWSE: 1760 - [YungShin Global Holding](https://aibio.space/companies/yungshin-global/) TWSE: 3705 - [PharmaEssentia](https://aibio.space/companies/pharmaessentia/) TWSE: 6446 - [Alar Pharmaceuticals](https://aibio.space/companies/alar-pharmaceuticals/) TPEX: 6785 - [Excelsior Biopharma](https://aibio.space/companies/excelsior-biopharma/) TPEX: 6496 - [Handa Pharmaceuticals](https://aibio.space/companies/handa-pharmaceuticals/) TPEX: 6620 - [Easywell Biomedicals](https://aibio.space/companies/easywell-biomedicals/) TPEX: 1799 - [Savior Lifetec](https://aibio.space/companies/savior-lifetec/) TPEX: 4167 ### Also on NASDAQ - [COMPASS Pathways Plc](https://aibio.space/companies/compass-pathways/) CMPS - [Bicycle Therapeutics](https://aibio.space/companies/bicycle-therapeutics/) BCYC - [InMed Pharmaceuticals](https://aibio.space/companies/inmed-pharmaceuticals/) INM - [Sana Biotechnology](https://aibio.space/companies/sana-biotechnology/) SANA - [TransCode Therapeutics](https://aibio.space/companies/transcode-therapeutics/) RNAZ - [Travere Therapeutics](https://aibio.space/companies/travere-therapeutics/) TVTX ## What SL Science Holding does SL Science Holding Limited is a Cayman Islands holding company that conducts its business through its subsidiary, SL Bio. The company describes itself as a biomedical company developing cellular and gene therapies, with a focus on regenerative medicine and cancer treatment. Its lead program is CD-19 Armed-T therapy, which uses bispecific antibodies to equip T cells, without genetic modification, to target blood cancers such as leukemia and lymphoma. The Armed-T technology is licensed from CytoArm Co., Ltd, a company registered in Taiwan, and the licensed patent applications have not yet been granted. A second program uses gamma delta T cell expansion technology, with work aimed at pancreatic and brain cancer models. The company hopes to use bovine-derived milk exosomes to regenerate damaged tissues, and it has exosome applications in skincare and cancer recovery. It expects to gradually phase out its legacy exosome cosmetic and plant supplement businesses as its cell therapies mature. All three product candidates are described as in pre-clinical trials, and the company has not submitted an IND application to the FDA. Its business model centres on partnerships with biopharmaceutical companies. | Product or program | What it is | Stage | |---|---|---| | CD-19 Armed-T Therapy | Engineered T cells with bispecific antibodies targeting CD-19 in blood cancers | pre-clinical trials | | GDT cell therapy | Expanded gamma delta T cells tested against pancreatic and brain cancer models | pre-clinical trials | | Exosome cosmetic and plant supplement businesses | Legacy exosome cosmetic and plant supplement lines | | Summarised from the company's [20-F filed Jun 18, 2026](https://www.sec.gov/Archives/edgar/data/2070534/000121390026070158/ea0293184-20f_slscience.htm). ## Questions about SL Science Holding Has SL Science Holding issued a going-concern warning? Our latest story on this, dated Jun 18, 2026: "SL Science closes Horizon Space Acquisition II deal, files shell company report". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/sl-science-closes-horizon-space-acquisition-ii-deal-files-shell/). Is SL Science Holding involved in a merger or acquisition? Our latest story on this, dated Jun 18, 2026: "SL Science closes Horizon Space Acquisition II deal, files shell company report". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/sl-science-closes-horizon-space-acquisition-ii-deal-files-shell/). What is the ticker symbol of SL Science Holding? SL Science Holding Limited trades under the ticker SLBT on NASDAQ. Where is SL Science Holding listed? SL Science Holding Limited is listed on NASDAQ. What is the SEC CIK of SL Science Holding? The SEC Central Index Key (CIK) for SL Science Holding Limited is 2070534. Its filings are on SEC EDGAR. Which country or territory is SL Science Holding listed under? Our directory records SL Science Holding Limited under Taiwan. What does SL Science Holding do? Our directory classifies SL Science Holding Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of SL Science Holding? The ISIN recorded for SL Science Holding Limited is KYG8191L1169. Does aibio.space cover SL Science Holding? aibio.space lists SL Science Holding Limited among 2,820 public biotech companies and publishes its news here as stories appear. Where is SL Science Holding incorporated? SEC records list its state or country of incorporation as E9. What does SL Science Holding develop? SL Science Holding Limited is a Cayman Islands holding company that conducts its business through its subsidiary, SL Bio. The company describes itself as a biomedical company developing cellular and gene therapies, with a focus on regenerative medicine and cancer treatment. What is CD-19 Armed-T Therapy from SL Science Holding? CD-19 Armed-T Therapy: Engineered T cells with bispecific antibodies targeting CD-19 in blood cancers Stage: pre-clinical trials. What is GDT cell therapy from SL Science Holding? GDT cell therapy: Expanded gamma delta T cells tested against pancreatic and brain cancer models Stage: pre-clinical trials. What is the latest SL Science Holding (SLBT) stock news? Our latest story on SL Science Holding, dated Jun 18, 2026: "SL Science closes Horizon Space Acquisition II deal, files shell company report". SL Science Holding completed its merger with Horizon Space Acquisition II on June 12, 2026. Its shell company report says its three product candidates are still in preclinical testing, and that its financial statements carry a going-concern warning. [Source](https://aibio.space/news/sl-science-closes-horizon-space-acquisition-ii-deal-files-shell/). How long will SL Science Holding's cash last? From our story of Jun 18, 2026: Its shell company report says its three product candidates are still in preclinical testing, and that its financial statements carry a going-concern warning. [Source](https://aibio.space/news/sl-science-closes-horizon-space-acquisition-ii-deal-files-shell/). ## Investor discussion: SL Science Holding Members talk about SL Science Holding (SLBT). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at SL Science Holding, newest first. Each line links the filing it comes from. 1. 2026-07-31 Financings Filed a registration statement for a share offering. SEC Form F-1. [Source](https://www.sec.gov/Archives/edgar/data/2070534/000110465926089195/tmb-20260331xf1.htm) 2. 2026-06-18 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 20-F. [Source](https://www.sec.gov/Archives/edgar/data/2070534/000121390026070158/ea0293184-20f_slscience.htm) 3. 2025-12-18 Mergers Filed documents for a merger or acquisition. SEC Form F-4. [Source](https://www.sec.gov/Archives/edgar/data/2070534/000121390025122905/ea0242738-07.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:SLBT on TradingView](https://www.tradingview.com/symbols/NASDAQ-SLBT/). ## SEC filings and registration - **SEC name**: SL Science Holding Ltd - **CIK**: 2070534 - **Industry (SIC)**: Biological Products, (No Diagnostic Substances) (2836) - **US tickers**: SLBT (Nasdaq) - **State or country of incorporation**: E9 - **Fiscal year ends**: December 31 - **Filer category**:
Emerging growth company - **Business address**: 11/F, NO. 479 CHONGYANG ROAD, TAIPEI CITY, 115010 - **Phone**: 886-2-26516826 ### Recent filings (8-K and 6-K are the company's own announcements) - [6-K](https://www.sec.gov/Archives/edgar/data/2070534/000110465926110392/tm2626021d1_6k.htm) filed 2026-09-24 - [6-K](https://www.sec.gov/Archives/edgar/data/2070534/000110465926104331/tm2623731d2_6k.htm) filed 2026-09-01 - [6-K](https://www.sec.gov/Archives/edgar/data/2070534/000110465926102108/tm2623731d1_6k.htm) filed 2026-08-27 - [6-K](https://www.sec.gov/Archives/edgar/data/2070534/000110465926082459/tm2620209d1_6k.htm) filed 2026-07-10 - [20-F](https://www.sec.gov/Archives/edgar/data/2070534/000121390026070158/ea0293184-20f_slscience.htm) filed 2026-06-18 - [6-K](https://www.sec.gov/Archives/edgar/data/2070534/000110465926073797/tm2617928d1_6k.htm) filed 2026-06-15 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002070534), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details SL Science Holding Limited is a public biotech or pharmaceutical company listed on NASDAQ under the ticker SLBT, recorded under Taiwan. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: SL Science Holding Limited - **Ticker**: SLBT - **Listing**: NASDAQ - **Country or territory**: Taiwan - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG8191L1169 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-SLBT/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/sl-science/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "SL Science Holding (SLBT) news: going concern and merger", 2026-10-31, https://aibio.space/companies/sl-science/